Jones BDM

Department of Psychiatry, University of Toronto, Toronto, Canada.

8 papers · ORCID

ArticlePsilocybin

Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.

Orsini DK, Wong S, Di Luch S +15

Europe PMC2026
ArticlePsilocybin

Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.

Wong S, Jones BDM, Thiyagarajah MT +10

Europe PMC2025
ArticlePsilocybin

Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.

Wong S, Meckling G, Fabiano N +11

Europe PMC2025
ArticlePsilocybin

Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.

Kittur ME, Burgos M LA, Jones BDM +4

Europe PMC2025
ArticlePsychedelics

Neural effects of psychedelics: Complexity the key word.

Jones BDM, Husain MI

Europe PMC2024
ArticlePsychedelics

A Systematic Review of Study Design and Placebo Controls in Psychedelic Research.

Wen A, Singhal N, Jones BDM +6

Europe PMC2024
ArticlePsilocybin

Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.

Wong S, Yu AY, Fabiano N +7

Europe PMC2024
ArticlePsilocybin

Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial.

Husain MI, Blumberger DM, Castle DJ +8

Europe PMC2023